CD274 and penile carcinoma: Although there have been case reports of metastatic disease in patients with penile carcinoma, several clinical trials are being carried out to evaluate the response to therapy directed against PDL1; in particular, NCT04224740 aims to evaluate the combination of cisplatin with pembrolizumab in patients with metastatic penile carcinoma.